Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Condition: Medulloblastoma Interventions: Procedure: Surgical resection; Procedure: Ommaya/VPS; Drug: Methotrexate; Drug: Cisplatin; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Carboplatin; Drug: Topotecan; Drug: Etoposide; Drug: Pegfilgrastim; Drug: Filgrastim; Radiation: Irradiation Sponsor: St. Jude Children's Research Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
GM-CLAG in Relapsed/Refractory FLT3-mutated AML
Condition: Acute Myeloid Leukemia Interventions: Drug: Gilteritinib 40 MG Oral Tablet; Drug: Cladribine; Drug: Cytarabine; Drug: Filgrastim; Drug: Mitoxantrone Sponsors: Gerhard C Hildebrandt; Astellas Pharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2022 Category: Research Source Type: clinical trials
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Conditions: Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory Interventions: Drug: Venetoclax; Drug: Azacitadine; Drug: Vorinostat; Drug: Cytarabine; Drug: Fludarabine; Drug: Filgrastim Sponsor: Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials
